Post Hoc Analyses of Surrogate Markers of Non-Alcoholic Fatty Liver Disease (NAFLD) and Liver Fibrosis in Patients With Type 2 Diabetes in a Digitally Supported Continuous Care Intervention
2This 2018 trial, funded by Virta Health, tested the impact of a high-compliance ketogenic diet on measures of liver health in Type 2 diabetics. Over one year, subjects saw significant improvements in measures of liver fat and fibrosis, with 61% of patients with abnormal ALT at baseline achieving ALT normalization. Among patients who showed significant weight loss and/or improvements in HbA1c, an even greater share achieved normal ALT levels. This trial suggests a ketogenic diet can significantly improve liver health in patients with Type 2 diabetes.
Read MorePost Hoc Analyses of Surrogate Markers of Non-Alcoholic Fatty Liver Disease (NAFLD) and Liver Fibrosis in Patients With Type 2 Diabetes in a Digitally Supported Continuous Care Intervention
Comments on 190525
71 Comments